Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene
Open Access
- 16 April 2002
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (8) , 5503-5508
- https://doi.org/10.1073/pnas.082100599
Abstract
Identification of mutations in the tumor suppressor gene TP53 has implications for the molecular epidemiology and for the molecular pathology of human cancer. We have developed and evaluated an arrayed primer extension assay for covering both strands of a region of the coding sequence containing more than 95% of the mutations described so far in TP53. On average, 97.5% of the arrayed TP53 gene sequence can be analyzed from either sense or antisense strands, and 81% from both strands. A patient DNA sample is amplified and annealed to arrayed primers, which then promote DNA polymerase extension reactions with four fluorescently labeled dideoxynucleotides. The TP53 gene chip spans exons 2–9 plus two introns from both strands. The performance of the assay was evaluated by using freshly extracted genomic DNA, as well as DNA extracted from archival (paraffin-embedded) DNA samples. The arrayed primer extension-based TP53 gene test provides an accurate and efficient tool for DNA sequence analysis of this frequently mutated gene for both research and clinical applications.Keywords
This publication has 21 references indexed in Scilit:
- APEX disease gene resequencing: mutations in exon 7 of the p53 tumor suppressor geneBioorganic & Medicinal Chemistry, 2001
- Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutantsCarcinogenesis: Integrative Cancer Research, 2001
- Evaluation of the Performance of a p53 Sequencing Microarray Chip Using 140 Previously Sequenced Bladder Tumor SamplesClinical Chemistry, 2000
- Arrayed Primer Extension: Solid-Phase Four-Color DNA Resequencing and Mutation Detection TechnologyGenetic Testing, 2000
- p53 Mutations and Expression in Ovarian CancersInternational Journal of Gynecological Pathology, 1999
- Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillaryelectrophoresis and allele specific polymerase chain reactionMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1998
- New dye-labeled terminators for improved DNA sequencing patternsNucleic Acids Research, 1997
- Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patientsNature Medicine, 1996
- Cystic fibrosis mutation detection by hybridization to light-generated DNA probe arraysHuman Mutation, 1996
- Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supportsNucleic Acids Research, 1994